Skip to content
drillr.ai
Sign up

MDT

Medtronic Plc

NYSE · Healthcare · Medical - Devices · IE

$105.55
+6.74%
Ask drillr

  • Nov 2, 2026, 23:46 UTC

    Medtronic plc shares rose 2.92% to close at $99.36 while the broader market fell.

    Source:

  • Oct 30, 2026, 05:47 UTC

    China’s Medtronic plc approved registration applications for four Medtronic products: a disposable magnetic-positioning mapping dual-energy ablation catheter, a cardiac dual-energy ablation system, a three-dimensional cardiac electrophysiology mapping system, and a disposable body-surface reference electrode.

    Source:

  • Oct 29, 2026, 22:51 UTC

    Medtronic plc shares rose 2.46% to $97.11 on the latest trading day.

    Source:

  • Oct 22, 2026, 11:00 UTC

    Medtronic announced positive real-world registry results for its Sphere-9 catheter and PulseSelect PFA System, covering prospectively enrolled patients with atrial fibrillation and ventricular tachycardia.

    Source:

  • Oct 19, 2026, 22:51 UTC

    Medtronic plc shares closed at $92.77, down 2.09% from the previous trading day.

    Source:

  • Oct 15, 2026, 14:00 UTC

    Medtronic completed the separation of MiniMed Group, Inc.

    Source:

  • Oct 13, 2026, 23:59 UTC

    Hadassah performed Israel’s first spine surgery using the Stealth Axis robotic system.

    Source:

  • Oct 12, 2026, 12:45 UTC

    Medtronic announced that its exchange offer for MiniMed Group shares was oversubscribed based on preliminary results.

    Source:

  • Oct 7, 2026, 21:31 UTC

    Medtronic announced a final exchange ratio of 4.5939 MiniMed common shares for each Medtronic ordinary share in its exchange offer.

    Source:

  • Oct 6, 2026, 13:15 UTC

    VB Spine LLC appointed Thomas E. Oglesby as its Chief Financial Officer, effective Sept. 16, 2026.

    Source:

  • Oct 1, 2026, 20:00 UTC

    Medtronic's AltaViva and Symplicity Spyral systems received Category I CPT code approval.

    Source:

  • Sep 30, 2026, 19:15 UTC

    Northwest Bank provided $34.5 million in acquisition financing to Luzern Associates for its purchase of a three-building industrial campus in Beverly, Massachusetts.

    Source:

  • Sep 30, 2026, 19:15 UTC

    Luzern Associates acquired a three-building, 200,000-square-foot industrial portfolio at Cherry Hill Business Park in Beverly, Massachusetts, from developer R J Kelly for $47.75 million.

    Source:

  • Sep 30, 2026, 13:00 UTC

    Medtronic received FDA clearance and CE Mark for its Affera Prism-2 Mapping Software and CE Mark for the PulseSelect ProxBox Adapter with Proximity Indicator software.

    Source:

  • Sep 17, 2026, 06:02 UTC

    Japan Medtronic began selling the ApexCut Blade, a surgical device for otolaryngology designed to reduce internal clogging during sinus surgery.

    Source:

  • Sep 16, 2026, 10:31 UTC

    The U.S. FDA approved Medtronic's Ligasure RAS Maryland device.

    Source:

  • Sep 16, 2026, 05:15 UTC

    Sonus Microsystems Inc. announced a collaboration with Medtronic plc to integrate its AI-powered Sonus Patch wearable ultrasound platform with Medtronic's Acute Care & Monitoring technology for a Gates Foundation-funded preeclampsia screening study in Kenya.

    Source:

  • Sep 11, 2026, 05:32 UTC

    China's National Healthcare Security Administration held an expert symposium on surgical robots in Beijing on September 11, 2026, with representatives from seven domestic and foreign surgical robot makers and five hospitals.

    Source:

  • Sep 9, 2026, 10:03 UTC

    Teleflex Inc. appointed Sean M. Salmon as a Director, effective September 8, 2026, and he will serve on the Growth and Operating Committee.

  • Sep 7, 2026, 01:51 UTC

    Medtronic (2041.HK) shares plunged on its first trading day, opening at HK$10, down 35.15% from the IPO price of HK$15.42, with a low of HK$9.99.

    Source:

  • Sep 6, 2026, 10:00 UTC

    Australia's Therapeutic Goods Administration (TGA) issued a confidential report alleging that Medtronic deliberately misled patients and doctors about the effectiveness of its Intellis spinal cord stimulator, based on unpublished real-world data showing poor performance.

    Source:

  • Sep 4, 2026, 08:30 UTC

    Medical device company Medcaptain Medical Technology (02041.HK) is set to list on the Hong Kong Stock Exchange on September 7, 2026, with its IPO priced at 15.41 HKD per share.

    Source:

  • Sep 1, 2026, 12:18 UTC

    Jishi Robotics announced a strategic partnership with Medtronic to expand global accessibility of robot-assisted surgery.

    Source:

  • Sep 1, 2026, 11:08 UTC

    Medtronic announced a $700 million investment in a robot surgeon.

    Source:

  • Sep 1, 2026, 10:51 UTC

    Medtronic plc reported Q1 FY2027 revenue of $9.756 billion, net income of $1.470 billion, and diluted EPS of $1.14, with organic revenue growth of 13.7%.

    Source:

  • Sep 1, 2026, 10:40 UTC

    Medtronic announced a partnership with Cornerstone Robotics.

    Source:

  • Aug 30, 2026, 23:55 UTC

    Medtronic plc reported Q2 EPS of $1.38, compared to $1.26 in the prior-year quarter.

    Source:

  • Aug 28, 2026, 01:09 UTC

    Medical solution provider Medcaptain Medical Technology (2041.HK) launched its Hong Kong IPO subscription on August 28, offering 38.9106 million H shares at HK$15.42 each to raise up to HK$600 million, with listing expected on September 7.

    Source:
Page 1Next →